会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • IMPROVED ENZYME VARIANTS OF LACTASE FROM KLUYVEROMYCES LACTIS
    • 来自KLUYVEROMYCES LACTIS的乳酸酶的改良酶变异
    • WO2015107050A1
    • 2015-07-23
    • PCT/EP2015/050503
    • 2015-01-13
    • DSM IP ASSETS B.V.
    • JONG, DE, René MarcelMÜLLER, Ulrike MariaDEKKER, Petrus Jacobus Theodorus
    • C12N9/38
    • C12N9/2471A23C9/1526A23L29/06A23V2002/00C12Y302/01107C12Y302/01108
    • The invention relates to a variant polypeptide having lactase activity. The invention also relates to a nucleic acid sequence encoding such a variant polypeptide, to a nucleic acid construct comprising said nucleic acid sequence, to a recombinant expression vector comprising said nucleic acid construct and to a recombinant host cell comprising said expression vector. Further, the invention relates to a method for producing a lactase variant via use of such a host cell. Also, the invention relates to a method of producing a lactase polypeptide variant. The invention further relates to a composition comprising a lactase variant, to use of such a lactase variant or to the use of a lactase variant-containing composition in the preparation of a dairy product, to a process for the production of a dairy product and to the resulting dairy product.
    • 本发明涉及具有乳糖酶活性的变体多肽。 本发明还涉及编码这种变体多肽的核酸序列,包含所述核酸序列的核酸构建体,包含所述核酸构建体的重组表达载体和包含所述表达载体的重组宿主细胞。 此外,本发明涉及通过使用这种宿主细胞产生乳糖酶变体的方法。 此外,本发明涉及产生乳糖酶多肽变体的方法。 本发明还涉及包含乳糖酶变体,使用这样的乳糖酶变体或在制备乳制品中使用含有乳糖酶变体的组合物的组合物,用于生产乳制品的方法,以及 产生的乳制品。
    • 4. 发明申请
    • ALPHA-AMYLASE VARIANTS
    • WO2014131842A1
    • 2014-09-04
    • PCT/EP2014/053853
    • 2014-02-27
    • DSM IP ASSETS B.V.
    • JONG, DE, René MarcelABBAS, Hanna ElisabetRIJ, VAN, Evert Tjeerd
    • C12N9/28A21D8/04C11D3/386
    • A21D8/042A21D10/005C12N9/2417C12Y302/01001
    • A variant polypeptide having alpha-amylase activity, wherein the variant has an amino acid sequence which, when aligned with the alpha-amylase comprising the sequence set out in SEQ ID NO: 2, comprises at least one substitution of an amino acid residue corresponding to any of amino acids 4, 6, 13, 14, 15, 16, 20, 45, 47, 51, 54, 61, 68, 69, 70, 71, 72, 73, 74, 75, 77, 78, 80, 82, 87, 88, 94, 95, 100, 103, 104, 117, 124, 125, 126, 128, 130, 133, 134, 136, 143, 144, 146, 168, 174, 177, 178, 183, 186, 188, 189, 190, 194, 195, 199, 200, 201, 204, 207, 210, 214, 217, 219, 222, 225, 227, 233, 234, 235, 236, 240, 251, 252, 254, 258, 259, 260, 261, 262, 263, 264, 266, 267, 269, 271, 273, 281, 282, 283, 284, 286, 288, 299, 322, 323, 325, 327, 328, 331, 334, 350, 356, 358, 367, 370, 371, 374, 377, 378, 388, 391, 414, 421, 422, 445, 450, 467, 488, 505, 536, 548, 554, 583, 588, 603, 637, 648, 651, 652, 660, 676, 677, said positions being defined with reference to SEQ ID NO: 2 and wherein the variant has one or more altered properties as compared with a reference polypeptide having alpha-amylase activity. Such a variant polypeptide may be used in the preparation of a baked product.
    • 具有α-淀粉酶活性的变体多肽,其中所述变体具有当与包含SEQ ID NO:2所示的序列的α-淀粉酶比对时的氨基酸序列包含至少一个对应于 任何氨基酸4,6,13,14,15,16,20,45,47,51,54,61,68,69,70,71,72,73,74,75,77,78,80, 82,87,88,94,95,100,103,104,117,124,125,126,128,130,133,134,136,143,144,146,168,174,177,178,183, 186,188,189,190,194,195,199,200,2201,204,207,210,214,217,219,222,225,227,233,234,235,236,240,251,252,252,218,218,218,218,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,2 254,258,258,260,261,262,263,264,266,262,263,264,266,276,263,264,266,276,263,267,271,273,281,282,283,284,286,288,29,322,236,265,276,262,263,264,266,262,263,264,266,266,263,264,266,266,263,264,266,266,263,264,266,266,263,264,266,266,263,264,266,266,263 331,334,350,356,358,367,370,371,374,377,378,388,391,414,421,422,445,450,467,468,505,536,548,554,583,537,537,536,535,536,358,367,350,356,358,367,350,356,358,367,370,356,358,367,370,356,358,367,370,356,358,367,370,356,358,367,375,356,358,336,375,356,336 588,603,637,648,651,652,660,676,677,所述位置参照SEQ ID NO:2定义,其中所述变异体 与具有α-淀粉酶活性的参考多肽相比,nt具有一个或多个改变的性质。 这样的变体多肽可用于制备焙烤产品。
    • 6. 发明申请
    • CARBOHYDRATE DEGRADING POLYPEPTIDE AND USES THEREOF
    • 碳水化合物降解聚糖及其用途
    • WO2014202621A1
    • 2014-12-24
    • PCT/EP2014/062743
    • 2014-06-17
    • DSM IP ASSETS B.V.
    • LOS, Alrik PieterJONG, DE, René MarcelAPPELDOORN, Maaike
    • C12N9/24C12N15/80C12P7/10D21C5/00
    • C12Y302/01139C12N9/2402C12N9/2437C12N9/2477C12N15/80C12P19/02C12P19/14D21C5/005D21C9/1036Y02E50/16
    • The invention relates to a polypeptide from Rasamsonia emersonii (Talaromyces emersonii) having hemicellulase or alpha-glucuronidase activity and which comprises the amino acid sequence set out in SEQ ID NO: 2 or 13 or an amino acid sequence encoded by the nucleotide sequence of SEQ ID NO:1, or a variant polypeptide or variant polynucleotide thereof, wherein the variant polypeptide has at least 70% sequence identity with the sequence set out in SEQ ID NO: 2 or 13 or the variant polynucleotide encodes a polypeptide that has at least 70% sequence identity with the sequence set out in SEQ ID NO: 2 or 13. The invention features the full length coding sequence of the novel gene as well as the amino acid sequence of the full-length functional protein and functional equivalents of the gene or the amino acid sequence. The invention also relates to methods for using the polypeptide in industrial processes. Also included in the invention are cells transformed with a polynucleotide according to the invention suitable for producing these proteins.
    • 本发明涉及具有半纤维素酶或α-葡糖醛酸糖苷酶活性的Rasamsonia emersonii(Talaromyces emersonii)的多肽,其包含SEQ ID NO:2或13所示的氨基酸序列或由SEQ ID NO:2所示的核苷酸序列编码的氨基酸序列 NO:1或其变体多肽或其变体多核苷酸,其中所述变体多肽与SEQ ID NO:2或13所示的序列具有至少70%的序列同一性,或所述变体多核苷酸编码具有至少70% 序列同一性与SEQ ID NO:2或13所示的序列一致。本发明的特征在于新基因的全长编码序列以及全长功能蛋白的氨基酸序列和基因的功能等同物 氨基酸序列。 本发明还涉及在工业过程中使用该多肽的方法。 本发明还包括用适合于生产这些蛋白质的根据本发明的多核苷酸转化的细胞。
    • 7. 发明申请
    • CARBOHYDRATE DEGRADING POLYPEPTIDE AND USES THEREOF
    • WO2014118360A3
    • 2014-08-07
    • PCT/EP2014/051998
    • 2014-02-03
    • DSM IP ASSETS B.V.
    • LOS, Alrik PieterJONG, DE, René MarcelAPPELDOORN, Maaike
    • C12N9/24C12R1/645
    • The invention relates to a polypeptide having hemicellulase activity which comprises the amino acid sequence set out in SEQ ID NO: 2, 7, 12, 17, 22, 27, 32, 37, 42, 47, 52, 57, 62, 67 or 72 or an amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 1, 6, 11, 16, 21, 26, 31, 36, 41, 46, 51, 56, 61, 66 or 71, SEQ ID NO: 4, 9, 14, 19, 24, 29, 34, 39, 44, 49, 54, 59, 64, 69 or 74, or a variant polypeptide or variant polynucleotide thereof, wherein the variant polypeptide has at least 75% sequence identity with the sequence set out in SEQ ID NO: 2, 7, 12, 17, 22, 27, 32, 37, 42, 47, 52, 57, 62, 67 or 72 or the variant polynucleotide encodes a polypeptide that has at least 75% sequence identity with the sequence set out in SEQ ID NO: 2, 7, 12, 17, 22, 27, 32, 37, 42, 47, 52, 57, 62, 67 or 72. The invention features the full length coding sequence of the novel gene as well as the amino acid sequence of the full-length functional protein and functional equivalents of the gene or the amino acid sequence. The invention also relates to methods for using the polypeptide in industrial processes. Also included in the invention are cells transformed with a polynucleotide according to the invention suitable for producing these proteins.